{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2023:CF5C7S6EIB46CXWRDJOYFUIFO4","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"a5144dbf92f88980c042e5ff36620419a92df9338969aef96359756dcf223037","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","primary_cat":"q-bio.CB","submitted_at":"2023-07-06T21:42:02Z","title_canon_sha256":"e72b572ead1fef6d34a377263784000a01db7a4ee7423721dd4e74b03efb5548"},"schema_version":"1.0","source":{"id":"2307.03308","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2307.03308","created_at":"2026-07-05T06:28:40Z"},{"alias_kind":"arxiv_version","alias_value":"2307.03308v1","created_at":"2026-07-05T06:28:40Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2307.03308","created_at":"2026-07-05T06:28:40Z"},{"alias_kind":"pith_short_12","alias_value":"CF5C7S6EIB46","created_at":"2026-07-05T06:28:40Z"},{"alias_kind":"pith_short_16","alias_value":"CF5C7S6EIB46CXWR","created_at":"2026-07-05T06:28:40Z"},{"alias_kind":"pith_short_8","alias_value":"CF5C7S6E","created_at":"2026-07-05T06:28:40Z"}],"graph_snapshots":[{"event_id":"sha256:bf82e97bb3c5520bd28493a34cd7e7f66d37aa4874ceb78be39dbd8c54ccfe17","target":"graph","created_at":"2026-07-05T06:28:40Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2307.03308/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Breast cancer is the leading type of cancer in women. About 10-15% of breast cancers are triple-negative breast cancer (TNBC), a subtype with the worst prognosis. Due to the lack of estrogen, progesterone and HER2 receptor expression, chemotherapies have been the standard of care for decades. Immunotherapy has emerged as promising for TNBC treatment. In 2020, the Food and Drug Administration (FDA) granted approval to pembrolizumab in combination with chemotherapy for patients with advanced triple-negative breast cancer. However, only a subgroup of advanced TNBC patients live longer whose tumor","authors_text":"Grace Sun, Sandip Patel","cross_cats":[],"headline":"","license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","primary_cat":"q-bio.CB","submitted_at":"2023-07-06T21:42:02Z","title":"Exploring The Contribution of Innate Immune Cells to Breast Cancer Immunotherapy"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2307.03308","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:567114a33eee4a92620dd3e06d4fd260535524cfbd89decd92d8833a32401312","target":"record","created_at":"2026-07-05T06:28:40Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"a5144dbf92f88980c042e5ff36620419a92df9338969aef96359756dcf223037","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","primary_cat":"q-bio.CB","submitted_at":"2023-07-06T21:42:02Z","title_canon_sha256":"e72b572ead1fef6d34a377263784000a01db7a4ee7423721dd4e74b03efb5548"},"schema_version":"1.0","source":{"id":"2307.03308","kind":"arxiv","version":1}},"canonical_sha256":"117a2fcbc44079e15ed11a5d82d105770a72222f3370a4572847a5a8daefb072","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"117a2fcbc44079e15ed11a5d82d105770a72222f3370a4572847a5a8daefb072","first_computed_at":"2026-07-05T06:28:40.688055Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T06:28:40.688055Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"XmnGsK3A5PYkPLjjGbNxVYwC+qjI/yB0qvQ+NAxF984lR3TbviGCB6YWQ+j3C+4BC2LZ/3jVzJjBk3ee7WU2Cg==","signature_status":"signed_v1","signed_at":"2026-07-05T06:28:40.688464Z","signed_message":"canonical_sha256_bytes"},"source_id":"2307.03308","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:567114a33eee4a92620dd3e06d4fd260535524cfbd89decd92d8833a32401312","sha256:bf82e97bb3c5520bd28493a34cd7e7f66d37aa4874ceb78be39dbd8c54ccfe17"],"state_sha256":"4e203eba586f696d49799db4aa9c3bc2506eef03767528386dc8876223b58ef4"}